Main Applications Of POCT

Acute cardiovascular disease such as acute myocardial infarction (AMI) is the most important cause of death in most cardiovascular diseases, and AM1, which really threatens the life safety of patients, only accounts for 1/4 of the total number of patients with chest pain. Patients with chest pain who are brought to the emergency department often undergo extensive diagnostic testing and diagnostic risk stratification for acute coronary syndrome and to determine the likelihood of future cardiac events. Experts believe that in order to ensure the selection of the appropriate POCT solution, healthcare professionals first need to evaluate the clinical, scientific and practical factors involved. Other chest pain patients do not need further treatment in the hospital. If the chest pain patient cannot be diagnosed with fatal AMI in a short period of time, then those non-AMI patients will not only be unreasonably fearful, but also have to bear extra large amounts of medicine every day. fees and hospital fees. Not only that, some patients with AMI may even die due to delayed diagnosis and lack of timely treatment. Therefore, rapid clinical diagnosis is very important for the rescue and treatment of patients and the control of disease progression. With the continuous development of testing technology, the clinical application of serum myocardial markers has received more and more attention in recent years. Among them, cardiac protein markers such as cardiac troponin I (cTnI) have high specificity and sensitivity to myocardial injury, and have become a definite marker for clinical diagnosis of myocardial injury, especially for the clinical diagnosis of acute myocardial infarction. .